Vanguard Group Inc Nephros Inc Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Nephros Inc stock. As of the latest transaction made, Vanguard Group Inc holds 204,158 shares of NEPH stock, worth $555,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

204,158

Previous 201,994 1.07%

Holding current value

$555,309

Previous $298,000 17.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$1.41 - $1.72 $3,051 - $3,722	2,164 Added 1.07%	204,158 $351,000
Q3 2024 Nov 13, 2024	BUY	$1.71 - $2.29 $13,628 - $18,251	7,970 Added 4.11%	201,994 $345,000
Q2 2024 Aug 13, 2024	BUY	$1.99 - $2.36 $36,566 - $43,365	18,375 Added 10.46%	194,024 $409,000
Q1 2024 May 10, 2024	BUY	$2.11 - $3.78 $9,155 - $16,401	4,339 Added 2.53%	175,649 $384,000
Q4 2023 Feb 14, 2024	BUY	$1.46 - $3.91 $873 - $2,338	598 Added 0.35%	171,310 $592,000
Q3 2023 Nov 14, 2023	BUY	$1.35 - $1.72 $8,658 - $11,032	6,414 Added 3.9%	170,712 $252,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $2.02 $20,078 - $35,578	17,613 Added 12.01%	164,298 $254,000
Q4 2022 Feb 10, 2023	SELL	$0.93 - $1.25 $1,021 - $1,372	-1,098 Reduced 0.74%	146,685 $170,000
Q3 2022 Nov 14, 2022	BUY	$0.91 - $1.87 $22,845 - $46,946	25,105 Added 20.46%	147,783 $134,000
Q2 2022 Aug 12, 2022	SELL	$1.47 - $4.63 $441 - $1,389	-300 Reduced 0.24%	122,678 $188,000
Q4 2021 Feb 14, 2022	BUY	$5.87 - $8.46 $125,383 - $180,705	21,360 Added 21.02%	122,978 $726,000
Q3 2021 Nov 12, 2021	BUY	$7.6 - $10.01 $12,783 - $16,836	1,682 Added 1.68%	101,618 $891,000
Q2 2021 Aug 13, 2021	BUY	$6.61 - $10.68 $660,576 - $1.07 Million	99,936 New	99,936 $1.01 Million

Others Institutions Holding NEPH

# of Institutions

Shares Held

4.24M

Call Options Held

Put Options Held

View Full List

About NEPHROS INC

Ticker NEPH
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 10,318,800
Market Cap $28.1M
Description
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...

More about NEPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Nephros Inc Transaction History